July/August #189 : The Genetic Fusion Inhibitor - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

Magnetic Attraction

A Shred of Understanding

Hold Your Horses

From the Editor

Accentuate the Positive

Feedback

Letters-July/August 2013

The POZ Q+A

Pride and Policy

POZ Planet

Say What?—Alicia Keys

Greetings from Ptown

PACHA Covers Trans Issues

Making Headlines

Latest Developments

Not Another Gay Sex Disease

Future Lovers

On a Roll

Voices

Yours in the Struggle

Care and Treatment

The Quest to Cure Another Baby

Viral Suppression Without Drugs?

The Genetic Fusion Inhibitor

New Retention Guidelines Urge Partnerships

Mapping Viral and Immune Coevolution

Research Notes

Prevention: PrEP May Be Cost-Effective

Treatement: Can Bees Sting Away HIV?

Cure: HDAC Inhibitors May Fight HIV Reservoir

Concerns: Hep C Transmission Among Gay Men

POZ Survey Says

Accentuate the Negative

POZ Heroes

Chemical Crusader

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

July / August 2013

The Genetic Fusion Inhibitor

by Benjamin Ryan

Two new studies of gene therapies that operate like the fusion inhibitor class of antiretrovirals further the hopes that scientists may develop ways to control HIV without drugs. Fusion inhibitors work by preventing the connection of HIV’s outer membrane with immune cell membranes.

In one study, researchers at the University of Pennsylvania and Sangamo BioSciences attached fusion inhibitor-like proteins to HIV coreceptors on CD4 cells, a process that blocked HIV infection in a test tube. They found that the coreceptors could still otherwise function normally, and theorized that such a treatment would probably not be toxic.

A study conducted by the Fred Hutchinson Cancer Research Institute in Seattle took blood-producing stem cells from the bone marrow of four pigtail macaque monkeys and modified them. In two of the monkeys, the researchers spliced in genetic instructions to express a protein to act like a fusion inhibitor. A year after the monkeys received the modified stem cells, they were infected with a highly aggressive form of simian HIV. One monkey, who had over half of its stem cells replaced, balanced out with a viral load of a few hundred, compared with 10,000 to 40,000 in the monkey who received just a 20 percent stem cell replacement. The control monkeys’ viral loads were a respective 300-fold and more than 1,400-fold higher by comparison.

The key to a successful genetic therapy is first finding combined methods that chip away at the viral reservoir where HIV hides from therapy, says Fred Hutchinson’s Patrick M. Younan, PhD. “And if we do that,” he says, “we could potentially use this [genetic fusion inhibitor] method to allow the immune system basically to control the virus replication once we decrease the pool.”

Search: gene therapy, fusion inhibitor, HIV coreceptors, Fred Hutchinson Cancer Research Institute

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adoniz89
    san dimas
    California


    koffeeboss
    Tucson
    Arizona


    sefarady
    New York
    California


    josebos
    Boston strong
    Massachusetts
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.